Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001437749-25-009910
Filing Date
2025-03-28
Accepted
2025-03-28 17:06:16
Documents
8
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM PRE 14A clnn20250312_pre14a.htm PRE 14A 796494
2 clenelogo17percent.jpg GRAPHIC 15272
3 clnn20230112_def14aimg002.jpg GRAPHIC 3362
4 clnn20230112_def14aimg003.jpg GRAPHIC 3654
5 comploss22p.jpg GRAPHIC 31006
6 comptsr22p.jpg GRAPHIC 32193
7 proxycardback.jpg GRAPHIC 88408
8 proxycardfront.jpg GRAPHIC 84494
  Complete submission text file 0001437749-25-009910.txt   1154209
Mailing Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121
Business Address 6550 SOUTH MILLROCK DRIVE, SUITE G50 SALT LAKE CITY UT 84121 801-676-9695
Clene Inc. (Filer) CIK: 0001822791 (see all company filings)

EIN.: 852828339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-39834 | Film No.: 25787497
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)